Join MediWales at BioWales in London to showcase Welsh life sciences and health technology organisations.  MediWales and Chambers Wales are delighted to announce our upcoming BioWales in London event on the 9th of March. Welsh Life sciences is a thriving and dynamic sector and particularly in the last 2 years, there have been significant developments around clinical innovation, medtech and diagnostics. This event showcases exciting new innovations, and companies looking for investment and collaboration opportunities. We will also have presentations from the Welsh NHS on how to engage with clinicians, collaborate on clinical studies and evaluations and support for regulatory compliance. Tying in with Wales Week in London, this event will provide opportunities to strengthen the collaborative partnerships between the London and Wales.

Programme:

Introduction and Welcome

MediWales Life Science Network for Wales: Gwyn Tudor, CEO (Chair).

Blake Mogan LLP Relevant Realistic Solutions

Chambers Wales Welcome Paul Slevin, President

Welsh Government Inward Investment Julie Russell, Business Development Manager

Welsh Company Showcase

Midatech Pharma Bio-delivery of Medicines: Steve Ellul, VP of Business Development.

Jellagen Next Generation Collagen for Regenerative Medicine: Andrew Mearns Spragg, CSO.

CanSense Innovation in Cancer Diagnostics.

Airway Medical Suction & Oxygen Therapy Equipment Glenn Kenworthy, CEO

BlueBox Optics Image guided surgery for Breast Cancer: Ron Yandle, CEO.

Creo Medical Advanced Energy in Therapeutic Endoscopy: Richard Lawrence, Head of Service Operations.

Forth Female Hormone Mapping: Pioneering Women’s Health Through AI Nicky Keay, Chief Medical Officer.

Glucose Republic Glucose Management through Digital and AI: David Haines, CEO.

Biophys Supporting Global Life Science from Wales: Michael Graz, CEO.

Funding and Finance

Panel discussion: support for companies on their investment journey and investment rounds.

Nick Rogers Chair: Destiny Pharma Plc

Ian Smith CEO: Bond Digital Health.

Alexander Leigh Senior Investment Executive: Development Bank of Wales

Andrew Mearns-Spragg CSO: Jellagen

Ian McKay Deputy Challenge Director: Innovate UK

Claire Button Co-CEO and Head of Life Sciences: Saturn Investors

Working with the Welsh NHS

Chair: Andrew Davies ABHI, Digital Health Lead

Welsh Government: Tom James, Head of Innovation and Technology

Cardiff and Vale University Health Board: Mark Briggs, Innovation Lead.

Velindre Cancer Centre: Robyn Davies, Innovation Lead.

Simbec-Orion An agile CRO for complex clinical studies: Julie Hodkinson, Senior Business Development Director

The Science Behind Clinical Trial Contract Research Services: Tonia Smreczak: Managing Director  

Networking Reception and Close The event will be held at the Blake Morgan office in London. Register for the event here.  

Event Exhibitors: Abel & Imray Capital Law Jellagen Teamworks ProtonDx